Viewing Study NCT07264634


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2025-12-26 @ 1:16 AM
Study NCT ID: NCT07264634
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-04
First Post: 2025-11-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Assess the Amount of Palopegteriparatide in Breast Milk of Lactating Females Requiring YORVIPATH® (Palopegteriparatide)
Sponsor: Ascendis Pharma A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module